Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person ERBB2 S310F shows stronger activation of downstream signalin...
| Class:Id | Summation:9665384 |
|---|---|
| _displayName | ERBB2 S310F shows stronger activation of downstream signalin... |
| _timestamp | 2019-10-30 21:53:19 |
| created | [InstanceEdit:9665383] Orlic-Milacic, Marija, 2019-10-30 |
| text | ERBB2 S310F shows stronger activation of downstream signaling than ERBB2 G309A and ERBB2 G309E, and is hyperphosphorylated on tyrosine residues in the C-tail (Greulich et al. 2012), while the C-tail phosphorylation of ERBB2 G309A (Bose et al. 2013) and ERBB2 G309E (Greulich et al. 2012) is comparable to the wild type ERBB2. Phosphorylation of EGFR was demonstrated in the presence of ERBB2 G309A (Bose et al. 2013). Except for ERBB2 C-tail tyrosine residues Y1221 and Y1222, which were shown to undergo trans-autophosphorylation in ERBB2 G309E, ERBB2 S310F and ERBB2 S310Y (Greulich et al. 2012), phosphorylation of specific tyrosine residues in ERBB2 and EGFR has not been examined and they are assumed to be the same as in the wild type ERBB2 heterodimers with EGFR. |
| (summation) | [Reaction:9665389] Heterodimers of ERBB2 ECD mutants and EGFR trans-autophosphorylate [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by ERBB2 S310F shows stronger activation of downstream signalin... (9665384)
